Free drug and ROS-responsive nanoparticle delivery of synergistic doxorubicin and olaparib combinations to triple negative breast cancer models (2024)

First Author: Cavanagh R
Attributed to:  Radiotherapy activated materials for enhanced cancer treatments funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/d3bm01931d

Publication URI: http://dx.doi.org/10.1039/d3bm01931d

Type: Journal Article/Review

Parent Publication: Biomaterials Science

Issue: 7